These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1307398)

  • 21. [The most important factor for active urinary stone formation in patients with urolithiasis].
    Simić-Ogrizović S; Dopsaj V; Jovicić S; Milenković D; Jovanović D; Nesić V
    Med Pregl; 2007; 60 Suppl 2():117-20. PubMed ID: 18928175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The significance of citrate excretion and calcium/citrate quotients in urine in patients with calcium calculi].
    Hofbauer J; Höbarth K; Zechner O
    Z Urol Nephrol; 1990 Nov; 83(11):597-602. PubMed ID: 2100085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
    Milosević D; Batinić D; Konjevoda P; Blau N; Stambuk N; Nizić L; Vrljicak K; Batinić D
    J Chem Inf Comput Sci; 2003; 43(6):1844-7. PubMed ID: 14632431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A correlation and path coefficient analysis of components of calciuria in normal subjects and idiopathic stone formers.
    Puche RC; Carlomagno AF; Gonzalez A; Sanchez A
    Bone Miner; 1987 Aug; 2(5):405-11. PubMed ID: 3505767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary citrate levels do not correlate with urinary pH in patients with urinary stone formation.
    Whitson JM; Cooperberg MR; Stackhouse GB; Stoller ML
    Urology; 2007 Oct; 70(4):634-7. PubMed ID: 17991528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of risk index according to Tiselius in patients with calcium urinary stones].
    Głuszek J; Raszeja-Wanic B; Boruczkowska A; Musialik D
    Pol Tyg Lek; 1989 Feb; 44(9):223-5. PubMed ID: 2813184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract].
    Nonomura M; Kawamura J; Ueda M; Okada Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1986 Mar; 32(3):311-25. PubMed ID: 3728237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Indication of the urinary citrate levels in idiopathic renal calculosis].
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1986 Mar; 116(12):371-3. PubMed ID: 3961456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Magnesium excretion in recurrent calcium urolithiasis].
    Pfab R; Hegemann M; Schütz W; Böttger I
    Urologe A; 1985 Sep; 24(5):296-8. PubMed ID: 4060380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of routine citrate analysis and calcium/citrate ratio in calcium urolithiasis.
    Höbarth K; Hofbauer J
    Eur Urol; 1991; 19(2):165-8. PubMed ID: 2022221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary metabolic evaluations in normal and stone forming children.
    DeFoor W; Asplin J; Jackson E; Jackson C; Reddy P; Sheldon C; Erhard M; Minevich E
    J Urol; 2006 Oct; 176(4 Pt 2):1793-6. PubMed ID: 16945651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urine citrate and renal stone disease.
    Goldberg H; Grass L; Vogl R; Rapoport A; Oreopoulos DG
    CMAJ; 1989 Aug; 141(3):217-21. PubMed ID: 2665909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of inhibitor deficiency in urolithiasis. II. Deficiency grade-adjusted and intermittent augmentation therapy for magnesium and citrate deficiency.
    Esen T; Akinci M; Tellaloğlu S; Koçak T
    Eur Urol; 1991; 19(3):244-8. PubMed ID: 1855531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical studies on recurrence of urolithiasis. (2) Hypercalciuria and recurrence of urolithiasis].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Nov; 33(11):1766-71. PubMed ID: 3445858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary glycosaminoglycan excretion in normal and stone-forming subjects: significant disturbance in recurrent stone formers.
    Nikkilä MT
    Urol Int; 1989; 44(3):157-9. PubMed ID: 2749930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Exaggerated calciuric response to an acute acid load in patients forming renal calcium stones].
    Normand M; Cayotte JL; Houillier P; Peuchant A; Paillard M
    Nephrologie; 1993; 14(6):283-5. PubMed ID: 8145886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.